Is JNJ stock a buy or a sell as questions continued to plague its Covid vaccine in July and JNJ stock remained rangebound?
Tesla Inc.'s record quarter earns some praise among investors, but the stock falls on a mix of concern for the near-term prospects for the Silicon Valley electric-car maker and less appetite for tech and tech-related names.
In states seeing surges, US health officials again recommend masking for all - including at schools.
Dr. Theo Hodge, a physician and infectious disease expert with the Washington Health Institute in Washington, D.C., is all too familiar with the disproportionate impact HIV has on the Black LGBTQ+ ...
The CAN SLIM Select list of the IBD Stock Screener has all the FAANG stocks. But those aren't necessarily the ones to focus on right now.
The price action of the ARK Innovation exchange-traded fund has weakened. Let's check on the charts and indicators. In this daily bar chart of ARKK, below, we can see that prices have slipped back below the 50-day and 200-day moving average lines.
Oil futures settle lower Tuesday as traders weigh worries over the delta variant of the coronavirus that causes COVID-19 and its impact on the economy, and energy demand.
Investors have rushed to exit bets on China's health sector this week, fearing that a regulatory crackdown that sparked panic selling in the tech and education sectors might hit the medical industry next. "Real estate, education, and healthcare are the three big mountains and the government inevitably has to tackle the issues," said Ming Liao, founding partner of Beijing-based private equity firm Prospect Avenue Capital. Selling has been fierce and although the Hang Seng healthcare index bounced 7% on Wednesday, it is still down about 11% for the week compared with a similar drop in the hard-hit Hang Seng Tech index and a 7.2% week-so-far plunge in the broader Hang Seng index.
Buybacks come around a year after the company took the leap of cutting its dividend.
HELSINKI/STOCKHOLM (Reuters) -Nokia on Thursday raised its full-year outlook after reporting a stronger-than-expected second-quarter operating profit, as the telecom equipment maker benefits from a sharp turnaround in its business. A round of changes in the company's operations, greater investment on research and a geopolitical situation tilting in its favour has put Nokia firmly back in the global 5G rollout race just a year after CEO Pekka Lundmark took the reins, allowing it to gain ground on Swedish arch-rival Ericsson. "Our 5G position has clearly strengthened ... we are winning back customers," Lundmark said on a call, confirming a rosier outlook first signalled in February.
(Bloomberg) -- China’s unprecedented crackdown on its technology industry has turned Tencent Holdings Ltd. from a market darling into the world’s biggest stock loser this month.The Chinese Internet giant had tumbled 23% in July as of Wednesday, set for its worst month ever after erasing about $170 billion of market value. That marks the fastest evaporation of shareholder wealth worldwide during this period, Bloomberg data shows. Nine of the top 10 losers in shareholder value this month are Chine
The oil giant has been able to return to investors money that the pandemic forced it to withhold last year.
BRUSSELS (Reuters) -Anheuser-Busch InBev, the world's largest brewer, underwhelmed on profit as costs increased and despite driving second-quarter revenue to above pre-pandemic levels. AB InBev retained its forecast that earnings before interest, tax, depreciation and amortisation (EBITDA) would grow by between 8% and 12% this year, with revenue increasing at a faster pace. In the second quarter, that profit figure rose 31% on a like-for-like basis to $4.85 billion, against consensus expectations for a 35% increase, according to a company-compiled consensus.
(Bloomberg) -- Stocks in China and Hong Kong jumped Thursday, after authorities intensified efforts to calm fears about a crackdown on the private education industry and as the central bank pumped liquidity into the financial system.The CSI 300 Index closed 1.9% higher, led by materials and industrial stocks. Hong Kong’s Hang Seng Index rallied 3.3%, as Meituan and Tencent Holdings Ltd. both climbed at least 9%. Technology shares extended gains after a report said China will continue to allow it
Shares of BioNTech (NASDAQ: BNTX) climbed sharply higher on Wednesday, gaining as much as 11% earlier in the session, though the stock ended the trading day up 10.3%. The biotechnology company is known for partnering with Pfizer (NYSE: PFE) to co-develop the BNT162b2 COVID-19 vaccine. BioNTech road Pfizer's coattails higher today as the company reported strong sales of its vaccine and raised its full-year forecast as a result.
ARK Invest's Cathie Wood continued to exit Chinese stocks after the country's regulators targeted the tutoring industry.
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons’ Euclidean Capital. If you want to skip our detailed analysis of Simons’ history, investment philosophy, and hedge fund performance, go directly to the 5 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean […]
(PYPL) stock was tumbling after the payments company beat second-quarter earnings forecasts but offered below-consensus guidance. PayPal reported an adjusted profit of $1.15 a share, beating forecasts for $1.13 on sales of $6.24 billion, missing analyst estimates for $6.27 billion. PayPal highlighted the impact of (EBAY)‘s transition to a “managed payments” system as one source of slower growth.
Santosh Rao, Manhattan Venture Partners Head of Research, joined Yahoo Finance to discuss Facebook’s latest earning results.
What happened Wednesday is shaping up to be a profitable day for cannabis investors. Here's how some of the most popular pot stocks were performing as of 12:30 p.m. EDT today: Sundial Growers (NASDAQ: SNDL), up 10% OrganiGram Holdings (NASDAQ: OGI), up 9% Aurora Cannabis (NASDAQ: ACB), up 8% Canopy Growth (NASDAQ: CGC), up 7% Hexo (NYSE: HEXO), up 7% So what The gains were sparked by a blockbuster earnings report from industry heavyweight Tilray (NASDAQ: TLRY).
The restaurateur posted earnings, which were actually pretty good. But it seems there was other news investors didn't like.